PXD021287
PXD021287 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Intact mass and middle-down analysis for mAbs |
| Description | An integrated strategy has been developed to characterize Trastuzumab and Adalimumab structural heterogeneity, which has prominent advantages in fast sample preparation with minimal artifacts, and complementary information obtained from intact mass and middle-down analyses. |
| HostingRepository | iProX |
| AnnounceDate | 2020-09-03 |
| AnnouncementXML | Submission_2020-09-03_02:36:40.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Wenwen Zhu |
| SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | maXis |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2020-09-03 02:33:25 | ID requested | |
| ⏵ 1 | 2020-09-03 02:36:40 | announced |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: mAbs structural heterogeneity, mass spectrometry, ETD-enabled QTOF |
Contact List
| Jinlan Zhang | |
|---|---|
| contact affiliation | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College |
| contact email | zhjl@imm.ac.cn |
| lab head | |
| Wenwen Zhu | |
| contact affiliation | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College |
| contact email | awen54jackson@gmail.com |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |
to receive all new ProteomeXchange dataset release announcements!
